FBT vs. SBIO
FBT (First Trust Amex Biotechnology Index) and SBIO (ALPS Medical Breakthroughs ETF) are both Health & Biotech Equities funds - FBT tracks the NYSE Arca Biotechnology Index while SBIO tracks the S-Network Medical Breakthroughs Index. Both are passively managed. Over the past 10 years, FBT returned 8.86%/yr vs 8.02%/yr for SBIO. Their correlation of 0.84 suggests significant overlap in exposure. FBT charges 0.57%/yr vs 0.50%/yr for SBIO.
Performance
FBT vs. SBIO - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, FBT achieves a 7.08% return, which is significantly higher than SBIO's -0.39% return. Over the past 10 years, FBT has outperformed SBIO with an annualized return of 8.86%, while SBIO has yielded a comparatively lower 8.02% annualized return.
FBT
- 1D
- 2.92%
- 1M
- 6.19%
- YTD
- 7.08%
- 6M
- 3.95%
- 1Y
- 35.94%
- 3Y*
- 12.40%
- 5Y*
- 6.79%
- 10Y*
- 8.86%
SBIO
- 1D
- 1.41%
- 1M
- -7.56%
- YTD
- -0.39%
- 6M
- 3.05%
- 1Y
- 65.41%
- 3Y*
- 17.80%
- 5Y*
- 2.68%
- 10Y*
- 8.02%
FBT vs. SBIO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
FBT First Trust Amex Biotechnology Index | 7.08% | 24.25% | 5.88% | 2.55% | -4.83% | -2.26% | 12.96% | 19.74% | -0.30% | 37.07% |
SBIO ALPS Medical Breakthroughs ETF | -0.39% | 55.07% | 3.81% | 8.68% | -28.08% | -17.55% | 21.17% | 50.30% | -11.81% | 45.67% |
Correlation
The correlation between FBT and SBIO is 0.69, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.69 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.72 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.78 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.82 |
Correlation (All Time) Calculated using the full available price history since Jan 2, 2015 | 0.84 |
The correlation between FBT and SBIO shifts across timeframes, from 0.69 (1 year) to 0.84 (all time), reflecting how their relationship changes across market environments.
FBT vs. SBIO - Sectors Allocation Comparison
Sectors
FBT
SBIO
Healthcare
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Financial Services
-
Industrials
-
-
Real Estate
-
-
Technology
-
-
Utilities
-
-
Healthcare
FBT
SBIO
Basic Materials
FBT
-
SBIO
-
Communication Services
FBT
-
SBIO
-
Consumer Cyclical
FBT
-
SBIO
-
Consumer Defensive
FBT
-
SBIO
-
Energy
FBT
-
SBIO
-
Financial Services
FBT
-
SBIO
Industrials
FBT
-
SBIO
-
Real Estate
FBT
-
SBIO
-
Technology
FBT
-
SBIO
-
Utilities
FBT
-
SBIO
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
FBT vs. SBIO — Risk / Return Rank
FBT
SBIO
FBT vs. SBIO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for First Trust Amex Biotechnology Index (FBT) and ALPS Medical Breakthroughs ETF (SBIO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| FBT | SBIO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.51 | ||
| Sortino ratioReturn per unit of downside risk | -0.54 | ||
| Omega ratioGain probability vs. loss probability | 1.31 | 1.36 | -0.05 |
| Calmar ratioReturn relative to maximum drawdown | 2.53 | 5.19 | -2.66 |
| Martin ratioReturn relative to average drawdown | 7.43 | 15.57 | -8.14 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| FBT | SBIO | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.74 | 2.24 | -0.51 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.31 | 0.08 | +0.23 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.37 | 0.24 | +0.13 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.51 | 0.21 | +0.30 |
Drawdowns
FBT vs. SBIO - Drawdown Comparison
The maximum FBT drawdown since its inception was -40.51%, smaller than the maximum SBIO drawdown of -63.06%. Use the drawdown chart below to compare losses from any high point for FBT and SBIO.
Loading charts...
Drawdown Indicators
| FBT | SBIO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -40.51% | -63.06% | +22.55% |
Max Drawdown (1Y)Largest decline over 1 year | -14.26% | -12.66% | -1.60% |
Max Drawdown (3Y)Largest decline over 3 years | -20.05% | -42.44% | +22.39% |
Max Drawdown (5Y)Largest decline over 5 years | -29.05% | -53.10% | +24.05% |
Max Drawdown (10Y)Largest decline over 10 years | -32.37% | -63.06% | +30.69% |
Current DrawdownCurrent decline from peak | -0.72% | -16.79% | +16.07% |
Average DrawdownAverage peak-to-trough decline | -11.17% | -28.45% | +17.28% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.85% | 4.22% | +0.63% |
Volatility
FBT vs. SBIO - Volatility Comparison
The current volatility for First Trust Amex Biotechnology Index (FBT) is 6.94%, while ALPS Medical Breakthroughs ETF (SBIO) has a volatility of 9.48%. This indicates that FBT experiences smaller price fluctuations and is considered to be less risky than SBIO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| FBT | SBIO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.94% | 9.48% | -2.54% |
Volatility (6M)Calculated over the trailing 6-month period | 15.87% | 22.70% | -6.83% |
Volatility (1Y)Calculated over the trailing 1-year period | 20.79% | 29.42% | -8.63% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 21.89% | 33.56% | -11.67% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 23.91% | 33.17% | -9.26% |
FBT vs. SBIO - Expense Ratio Comparison
FBT has a 0.57% expense ratio, which is higher than SBIO's 0.50% expense ratio.
Dividends
FBT vs. SBIO - Dividend Comparison
Neither FBT nor SBIO has paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
FBT First Trust Amex Biotechnology Index | 0.00% | 0.00% | 0.71% | 0.00% | 0.00% | 1.37% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.12% |
SBIO ALPS Medical Breakthroughs ETF | 0.00% | 0.00% | 3.55% | 0.22% | 0.00% | 0.00% | 0.00% | 0.04% | 2.79% | 1.77% | 0.00% | 0.00% |
Frequently Asked Questions
FBT and SBIO have a correlation of 0.69, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
SBIO has higher volatility (9.48%) compared to FBT (6.94%). In terms of maximum drawdown, FBT dropped -40.51% vs SBIO's -63.06%.
On 10-year performance, FBT leads with 8.86% vs 8.02% for SBIO. On fees, SBIO is cheaper at 0.50% per year. On volatility, FBT has been the lower-risk option at 6.94%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, FBT has performed better with a 8.86% return vs 8.02%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
SBIO is cheaper with a 0.50% expense ratio, compared with 0.57% for FBT.
FBT and SBIO have nearly identical dividend yields, around 0.00%.
FBT tracks NYSE Arca Biotechnology Index, while SBIO tracks S-Network Medical Breakthroughs Index. They also come from different issuers: First Trust and SS&C. Their fees differ too: 0.57% for FBT and 0.50% for SBIO.
SBIO currently has the higher Sharpe Ratio (2.24 vs 1.74), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for FBT and SBIO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer